Aanjaneya Lifecare is currently trading at Rs36.60, up by 0.55 points or 1.53% from its previous closing of Rs. 36.05 on the BSE.
The scrip opened at Rs 35.85 and has touched a high and low of Rs. 38.50 and Rs 33.20 respectively. So far 11476 shares were traded on the counter.
The BSE group 'B' stock of face value Rs 10 has touched a 52 week high of Rs 850.70 on 18-Jan-2013 and a 52 week low of Rs 35.85 on 26-Jul-2013.
Last one week high and low of the scrip stood at Rs 44.45 and Rs 33.20 respectively. The current market cap of the company is Rs 49.44 crore.
The promoters holding in the company stood at 25.35% while Institutions and Non-Institutions held 1.68% and 72.97% respectively.
Aanjaneya Lifecare (ALL) has become holding Company of ‘Fair Success (H.K)’ a Company incorporated in the Hong Kong, by way of acquiring 100% ordinary share capital of the said Hong Kong based Company.
The company has also incorporated Wholly owned Subsidiary named ‘Dr. Datsons Labs’ a Company incorporated in United Kingdom, by way of subscribing 100% ordinary share capital of the said Subsidiary Company.
Aanjaneya Lifecare is a leading research based integrated pharmaceutical company with established research, manufacturing and marketing capabilities. It is R&D focused, has a multi product portfolio with state of the art manufacturing facilities, and is set to become a marketing conglomerate across the globe.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: